Sai Parenterals secures $5.82M equity investment from Marquee investors
Sai Parenterals has announced the successful completion of a USD 5.82 million (Rs 50 crore) equity investment round by a group of…
Author
Dr Reddy’s and Sun Pharma recall products in US due to manufacturing issues
While Dr Reddy's Laboratories is recalling a drug used to treat sneezing, runny or stuffy nose, Sun Pharma is recalling cartons of…
Lupin gets FDA nod to market generic antibiotic medicine in US
Doxycyline capsule is a generic equivalent of Galderma Laboratories' Oracea capsules
Aurobindo units recall products in US market for manufacturing issues
The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the…
Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
50 million doses of Covaxin set to expire early 2023
Due to lack of product demand, production stoppage of Covaxin - a two dose jab, was initiated by Bharat Biotech earlier this year,…
India looking at greater market access for pharma products in UK under proposed FTA: Official
The official said that both the countries are trying to secure a deal which is in their national interest
US FDA issues warning letter to Lupin for Maharashtra-based API plant
The FDA inspected the manufacturing facility from 22nd March to 4th April, 2022
USFDA issues import alert on Glenmark Pharma’s Baddi plant
As per the USFDA, import alert 66-40 implies detention without physical examination of drugs from firms which have not met drug…
HPV vaccine production delayed due to COVID focus: SII
The Serum Institute of India (SII) will start supplying the HPV vaccine to the Indian government in early 2023